Current Issue
February 2025
Thrown into Disarray
The sudden withdrawal of voxelotor from the market left physicians and patients scrambling for answers and reverting to older treatments for sickle cell disease.
Viewpoints
Editor’s Corner
“Scope Creep” Debate Between AMA, AAPA Fails to Put Patients First
Advanced Practitioner Voices
Many Factors Contribute to Rising Rates of Burnout Among APs
Education
You Make the Call
You Make the Call Readers' Response
Would you treat this patient for myelodysplastic syndromes or paroxysmal nocturnal hemoglobinuria?
Spotlight
The Search for Research
Bevacizumab in Hereditary Hemorrhagic Telangiectasia (TRUST-HHT; NCT04404881)
Gerofit Exercise Intervention for Older Adults with Sickle Cell Disease (SICKLE-FIT; NCT05714098)
Feature Articles
Blood Beyond Borders
Opportunities Expanding for Researchers in LMICs to Publish Findings
News
In a Different Vein: News from the Blood Journals
EMD Lesions Comprise Multicellular Ecosystems With New Therapeutic Avenues
Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study
Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH
Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP
Literature Scan
IL-1β Inhibitor Canakinumab May Be Effective in Specific Genetic Subsets of Lower-Risk MDS
MRD Status Important Prognostic Factor for R/R MM Treated With T-Cell Redirecting Therapies
Therapy-Related Acute Leukemia Following AHCT for MM Remains Uncommon, Outcomes Remain Poor in Retrospective Analysis
CRP Levels May Help Stratify VTE Risk in Patients With Cancer on ICIs
ASH Directions
ASH Publishes Guide to Boosting Accessibility, Diversity in Clinical Trials
Data Stream
Online Exclusives
In a Different Vein: News from the Blood Journals
Anxiety, Depression Elevated in Patients with Histiocytic Neoplasms
Literature Scan
Connect with us:
CURRENT ISSUE
February 2025
